Literature DB >> 16554667

Renal tubular drug transporters.

Vincent Launay-Vacher1, Hassane Izzedine, Svetlana Karie, Jean Sébastien Hulot, Alain Baumelou, Gilbert Deray.   

Abstract

The kidney plays an important role in the elimination of numerous hydrophilic xenobiotics, including drugs, toxins, and endogenous compounds. It has developed high-capacity transport systems to prevent urinary loss of filtered nutrients, as well as electrolytes, and simultaneously to facilitate tubular secretion of a wide range of organic ions. Transport systems for organic anions and cations are primarily involved in the secretion of drugs in renal tubules. The identification and characterization of organic anion and cation transporters have been progressing at the molecular level. To date, many members of the organic anion transporter, organic cation transporter, and organic anion-transporting polypeptide families have been found to mediate the transport of diverse organic ions. It has also been suggested that ATP-dependent primary active transporters such as MDR1/P-glycoprotein and the multidrug resistance-associated protein family function as efflux pumps of renal tubular cells for more hydrophobic molecules and anionic conjugates. Tubular reabsorption of peptide-like drugs such as beta-lactam antibiotics across the brush-border membranes appears to be mediated by two distinct H+/peptide cotransporters: PEPT1 and PEPT2. Renal disposition of drugs occurs through interaction with these diverse secretory and absorptive transporters in renal tubules. Studies of the functional characteristics, such as substrate specificity and transport mechanisms, and of the localization of drug transporters could provide information regarding the cellular network involved in renal handling of drugs. Detailed information concerning molecular and cellular aspects of drug transporters expressed in the kidney has facilitated studies of the mechanisms underlying renal disposition as well as transporter-mediated drug interactions. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554667     DOI: 10.1159/000092212

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  29 in total

1.  Disposition kinetics of a dipeptide ester prodrug of acyclovir and its metabolites following intravenous and oral administrations in rat.

Authors:  Ravi S Talluri; Ripal Gaudana; Sudharshan Hariharan; Ritesh Jain; Ashim K Mitra
Journal:  Clin Res Regul Aff       Date:  2009-01-01

2.  Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).

Authors:  Manthena V Varma; Stefanus J Steyn; Charlotte Allerton; Ayman F El-Kattan
Journal:  Pharm Res       Date:  2015-07-09       Impact factor: 4.200

3.  Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.

Authors:  František Trejtnar; Jana Mandíková; Jana Kočíncová; Marie Volková
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

4.  Combined Structural and Functional Imaging of the Kidney Reveals Major Axial Differences in Proximal Tubule Endocytosis.

Authors:  Claus D Schuh; Marcello Polesel; Evgenia Platonova; Dominik Haenni; Alkaly Gassama; Natsuko Tokonami; Susan Ghazi; Milica Bugarski; Olivier Devuyst; Urs Ziegler; Andrew M Hall
Journal:  J Am Soc Nephrol       Date:  2018-10-09       Impact factor: 10.121

5.  Multiphoton imaging reveals axial differences in metabolic autofluorescence signals along the kidney proximal tubule.

Authors:  Milica Bugarski; Joana Raquel Martins; Dominik Haenni; Andrew M Hall
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-22

6.  Mechanistic models describing active renal reabsorption and secretion: a simulation-based study.

Authors:  Melanie A Felmlee; Rutwij A Dave; Marilyn E Morris
Journal:  AAPS J       Date:  2012-11-30       Impact factor: 4.009

7.  In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury.

Authors:  Andrew M Hall; George J Rhodes; Ruben M Sandoval; Peter R Corridon; Bruce A Molitoris
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

8.  Renal excretion of apricitabine in rats: ex vivo and in vivo studies.

Authors:  Mariana Babayeva; Susan Cox; Michael P White; David R Taft
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-04-06       Impact factor: 2.441

9.  Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.

Authors:  Lesley A Stevens; Thomas D Nolin; Michelle M Richardson; Harold I Feldman; Julia B Lewis; Roger Rodby; Raymond Townsend; Aghogho Okparavero; Yaping Lucy Zhang; Christopher H Schmid; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-05-17       Impact factor: 8.860

10.  Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

Authors:  Xiao-Yan Chu; Yuexia Liang; Xiaoxin Cai; Karla Cuevas-Licea; Ronda K Rippley; Kelem Kassahun; Magang Shou; Matthew P Braun; George A Doss; M Reza Anari; Raymond Evers
Journal:  Pharm Res       Date:  2008-12-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.